Literature DB >> 10210691

Drinking water arsenic in Utah: A cohort mortality study.

D R Lewis1, J W Southwick, R Ouellet-Hellstrom, J Rench, R L Calderon.   

Abstract

The association of drinking water arsenic and mortality outcome was investigated in a cohort of residents from Millard County, Utah. Median drinking water arsenic concentrations for selected study towns ranged from 14 to 166 ppb and were from public and private samples collected and analyzed under the auspices of the State of Utah Department of Environmental Quality, Division of Drinking Water. Cohort members were assembled using historical documents of the Church of Jesus Christ of Latter-day Saints. Standard mortality ratios (SMRs) were calculated. Using residence history and median drinking water arsenic concentration, a matrix for cumulative arsenic exposure was created. Without regard to specific exposure levels, statistically significant findings include increased mortality from hypertensive heart disease [SMR = 2.20; 95% confidence interval (CI), 1.36-3.36], nephritis and nephrosis (SMR = 1.72; CI, 1.13-2.50), and prostate cancer (SMR = 1.45; CI, 1.07-1. 91) among cohort males. Among cohort females, statistically significant increased mortality was found for hypertensive heart disease (SMR = 1.73; CI, 1.11-2.58) and for the category of all other heart disease, which includes pulmonary heart disease, pericarditis, and other diseases of the pericardium (SMR = 1.43; CI, 1.11-1.80). SMR analysis by low, medium, and high arsenic exposure groups hinted at a dose relationship for prostate cancer. Although the SMRs by exposure category were elevated for hypertensive heart disease for both males and females, the increases were not sequential from low to high groups. Because the relationship between health effects and exposure to drinking water arsenic is not well established in U.S. populations, further evaluation of effects in low-exposure populations is warranted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210691      PMCID: PMC1566417          DOI: 10.1289/ehp.99107359

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  40 in total

Review 1.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

2.  Concentration and chemical species of arsenic in human tissue.

Authors:  H Yamauchi; Y Yamamura
Journal:  Bull Environ Contam Toxicol       Date:  1983-09       Impact factor: 2.151

3.  Neurologic evaluation of a population exposed to arsenic in Alaskan well water.

Authors:  K Kreiss; M M Zack; P J Landrigan; R G Feldman; C A Niles; J Chirico-Post; D S Sax; M H Boyd; D H Cox
Journal:  Arch Environ Health       Date:  1983 Mar-Apr

4.  A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska.

Authors:  J M Harrington; J P Middaugh; D L Morse; J Housworth
Journal:  Am J Epidemiol       Date:  1978-11       Impact factor: 4.897

5.  Skin cancer and water arsenic in Lane County, Oregon.

Authors:  W Morton; G Starr; D Pohl; J Stoner; S Wagner; D Weswig
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

6.  Cancer incidence in Mormons and non-Mormons in Utah, 1966-1970.

Authors:  J L Lyon; M R Klauber; J W Gardner; C R Smart
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

7.  Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers.

Authors:  C J Chen; Y C Chuang; T M Lin; H Y Wu
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

8.  The metabolism of arsenite and arsenate by the rat.

Authors:  S Lerman; T W Clarkson
Journal:  Fundam Appl Toxicol       Date:  1983 Jul-Aug

9.  Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic.

Authors:  W P Tseng
Journal:  Environ Health Perspect       Date:  1977-08       Impact factor: 9.031

10.  A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan.

Authors:  C J Chen; Y C Chuang; S L You; T M Lin; H Y Wu
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

View more
  92 in total

Review 1.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

2.  Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study.

Authors:  Maria Argos; Tara Kalra; Paul J Rathouz; Yu Chen; Brandon Pierce; Faruque Parvez; Tariqul Islam; Alauddin Ahmed; Muhammad Rakibuz-Zaman; Rabiul Hasan; Golam Sarwar; Vesna Slavkovich; Alexander van Geen; Joseph Graziano; Habibul Ahsan
Journal:  Lancet       Date:  2010-06-18       Impact factor: 79.321

3.  Geostatistics: a common link between medical geography, mathematical geology, and medical geology.

Authors:  P Goovaerts
Journal:  J South Afr Inst Min Metall       Date:  2014-08       Impact factor: 0.807

4.  Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice.

Authors:  Nicole V Soucy; Debra Mayka; Linda R Klei; Antonia A Nemec; John A Bauer; Aaron Barchowsky
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

5.  Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers.

Authors:  Fen Wu; Farzana Jasmine; Muhammad G Kibriya; Mengling Liu; Oktawia Wójcik; Faruque Parvez; Ronald Rahaman; Shantanu Roy; Rachelle Paul-Brutus; Stephanie Segers; Vesna Slavkovich; Tariqul Islam; Diane Levy; Jacob L Mey; Alexander van Geen; Joseph H Graziano; Habibul Ahsan; Yu Chen
Journal:  Am J Epidemiol       Date:  2012-04-24       Impact factor: 4.897

6.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

7.  Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.

Authors:  Yu Chen; Faruque Parvez; Mary Gamble; Tariqul Islam; Alauddin Ahmed; Maria Argos; Joseph H Graziano; Habibul Ahsan
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-27       Impact factor: 4.219

8.  Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh.

Authors:  Wen-Chi Pan; Wei Jie Seow; Molly L Kile; Elaine B Hoffman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Golam Mostofa; Quan Lu; David C Christiani
Journal:  Am J Epidemiol       Date:  2013-09-18       Impact factor: 4.897

Review 9.  Liver is a target of arsenic carcinogenesis.

Authors:  Jie Liu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

10.  Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

Authors:  Jaymie R Meliker; Melissa J Slotnick; Gillian A AvRuskin; David Schottenfeld; Geoffrey M Jacquez; Mark L Wilson; Pierre Goovaerts; Alfred Franzblau; Jerome O Nriagu
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.